Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adrenoleukodystrophy

H W Moser1

  • 1Kennedy Krieger Institute, Baltimore, Maryland, USA.

Current Opinion in Neurology
|June 1, 1995
PubMed
Summary
This summary is machine-generated.

Genetic mutations confirm adrenoleukodystrophy (ALD) diagnosis, but Lorenzo's Oil shows limited efficacy in symptomatic patients. Early dietary intervention may mitigate neurological decline in ALD.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A PEX10 defect in a patient with no detectable defect in peroxisome assembly or metabolism in cultured fibroblasts.

Journal of inherited metabolic disease·2009
Same author

Magnetization transfer MRI demonstrates spinal cord abnormalities in adrenomyeloneuropathy.

Neurology·2005
Same author

Spectroscopic evidence of cerebral axonopathy in patients with "pure" adrenomyeloneuropathy.

Neurology·2005
Same author

Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy.

Neurology·2003
Same author

Clinical and electrophysiological improvement of adrenomyeloneuropathy with steroid treatment.

Journal of neurology, neurosurgery, and psychiatry·2003
Same author

MRI and proton MRSI in women heterozygous for X-linked adrenoleukodystrophy.

Neurology·2003
Same journal

Movement disorders and Parkinson's disease: collaborative and interdisciplinary research to advance understanding of neural circuit dysfunction, pathophysiology, and care: new horizons in technology, neuroimaging, neurophysiology, and genetics toward personalized medicine.

Current opinion in neurology·2026
Same journal

Editorial introduction.

Current opinion in neurology·2026
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
See all related articles

Area of Science:

  • Genetics
  • Neurology
  • Biochemistry

Background:

  • Adrenoleukodystrophy (ALD) is a rare genetic disorder affecting the adrenal glands and nervous system.
  • Advances in understanding ALD have focused on its genetic basis and therapeutic interventions.

Purpose of the Study:

  • To confirm genetic abnormalities in the putative ALD gene.
  • To evaluate the efficacy of Lorenzo's Oil and dietary therapy in managing ALD.

Main Methods:

  • Genetic analysis of 80 ALD families worldwide.
  • Clinical follow-up of patients treated with Lorenzo's Oil and dietary interventions.

Main Results:

  • Mutations in the ALD gene were confirmed in all studied families.

Related Experiment Videos

  • A specific dinucleotide deletion was found in 20% of families; other mutations were unique.
  • No correlation was observed between mutation type/location and patient phenotype.
  • Lorenzo's Oil did not alter the disease course in symptomatic patients.
  • Early dietary therapy may reduce neurological disability frequency and severity.

    • Conclusions:

    • Genetic confirmation of ALD is robust, with diverse mutations identified.
    • Lorenzo's Oil is ineffective for symptomatic ALD patients.
    • Proactive dietary management before symptom onset is crucial for mitigating neurological impact in ALD.